Endothelium-dependent cerebral artery dilation mediated by transient receptor potential and Ca 2+-activated K + channels

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 2, 2011, Pages 148-153

  Earley, Scott ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

cation channels; endothelium; smooth muscle; TRP channels

Indexed keywords

ALLICIN; ALLYL ISOTHIOCYANATE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CAPSAICIN; CAPSAZEPINE; CARVACROL; EPOXYICOSATRIENOIC ACID; EUGENOL; HC 030031; MENTHOL; PROTEIN INHIBITOR; RUTHENIUM RED; THYMOL; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLIN; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 3;

ARTERY DILATATION; BRAIN ARTERY; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONFERENCE PAPER; ENDOTHELIUM CELL; GARLIC; HEART PROTECTION; HUMAN; MEMBRANE POTENTIAL; NONHUMAN; OREGANO; PEPPER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; CEREBRAL ARTERIES; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPV CATION CHANNELS;

EID: 79951558335     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181f580d9     Document Type: Conference Paper

References (60)

1. Ledoux J, Taylor MS, Bonev AD, et al. Functional architecture of inositol 1,4,5-trisphosphate signaling in restricted spaces of myoendothelial projections. Proc Natl Acad Sci U S A. 2008;105:9627-9632. (Pubitemid 352031351)
2. Nelson MT, Cheng H, Rubart M, et al. Relaxation of arterial smooth muscle by calcium sparks. Science. 1995;270:633-637.
3. Earley S, Gonzales AL, Garcia ZI. A dietary agonist of transient receptor potential cation channel V3 elicits endothelium-dependent vasodilation. Mol Pharmacol. 2010;77:612-620.
4. Earley S, Gonzales AL, Crnich R. Endothelium-dependent cerebral artery dilation mediated by TRPA1 and Ca2+-Activated K+ channels. Circ Res. 2009;104:987-994.
5. Earley S, Heppner TJ, Nelson MT, et al. TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels. Circ Res. 2005;97:1270-1279.
6. Butler A, Tsunoda S, McCobb DP, et al. mSlo, a complex mouse gene encoding ''maxi'' calcium-activated potassium channels. Science. 1993; 261:221-224. (Pubitemid 23265401)
7. Tseng-Crank J, Foster CD, Krause JD, et al. Cloning, expression, and distribution of functionally distinct Ca(2+)-activated K+ channel isoforms from human brain. Neuron. 1994;13:1315-1330.
8. Knaus HG, Eberhart A, Glossmann H, et al. Pharmacology and structure of high conductance calcium-activated potassium channels. Cell Signal. 1994;6:861-870.
9. Tanaka Y, Meera P, Song M, et al. Molecular constituents of maxi KCa channels in human coronary smooth muscle: predominant alpha + beta subunit complexes. J Physiol. 1997;502(pt 3):545-557. (Pubitemid 27365820)
10. Sanchez M, McManus OB. Paxilline inhibition of the alpha-subunit of the high-conductance calcium-activated potassium channel. Neuropharma-cology. 1996;35:963-968. (Pubitemid 26377682)
11. Galvez A, Gimenez-Gallego G, Reuben JP, et al. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990;265:11083-11090.
12. Barrett JN, Magleby KL, Pallotta BS. Properties of single calcium-activated potassium channels in cultured rat muscle. J Physiol. 1982;331: 211-230. (Pubitemid 12002600)
13. Jaggar JH, Porter VA, Lederer WJ, et al. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol. 2000;278:C235-C256. (Pubitemid 30131140)
14. Eichler I, Wibawa J, Grgic I, et al. Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation. Br J Pharmacol. 2003;138: 594-601. (Pubitemid 36315307)
15. Joiner WJ, Wang LY, Tang MD, et al. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci U S A. 1997;94:11013-11018. (Pubitemid 27430852)
16. Ishii TM, Silvia C, Hirschberg B, et al. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A. 1997;94:11651-11656. (Pubitemid 127650718)
17. Grissmer S, Nguyen AN, Cahalan MD. Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology. J Gen Physiol. 1993;102:601-630. (Pubitemid 23328148)
18. Wulff H, Miller MJ, Hansel W, et al. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A. 2000; 97:8151-8156. (Pubitemid 30460788)
19. Taylor MS, Bonev AD, Gross TP, et al. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res. 2003;93:124-131. (Pubitemid 36919699)
20. Hosseini R, Benton DC, Dunn PM, et al. SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neurones. J Physiol. 2001;535:323-334. (Pubitemid 32825672)
21. Pak WL, Grossfield J, Arnold KS. Mutants of the visual pathway of Drosophila melanogaster. Nature. 1970;227:518-520.
22. Hotta Y, Benzer S. Genetic dissection of the Drosophila nervous system by means of mosaics. Proc Natl Acad Sci U S A. 1970;67:1156-1163.
23. Montell C, Rubin GM. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduc-tion. Neuron. 1989;2:1313-1323.
24. Colbert HA, Smith TL, Bargmann CI. OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensa-tion, and olfactory adaptation in Caenorhabditis elegans. J Neurosci. 1997;17:8259-8269. (Pubitemid 27461050)
25. Palmer CP, Zhou XL, Lin J, et al. A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca(2+)-permeable channel in the yeast vacuolar membrane. Proc Natl Acad Sci U S A. 2001;98:7801-7805. (Pubitemid 32642641)
26. Wes PD, Chevesich J, Jeromin A, et al. TRPC1, a human homolog of a Drosophila store-operated channel. Proc Natl Acad Sci U S A. 1995;92: 9652-9656.
27. Nilius B, Owsianik G, Voets T, et al. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87:165-217. (Pubitemid 46207713)
28. Duncan LM, Deeds J, Hunter J, et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998;58:1515-1520. (Pubitemid 28193617)
29. Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov. 2009;8:55-68.
30. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J. 2009;23: 297-328.
31. Damann N, Voets T, Nilius B. TRPs in our senses. Curr Biol. 2008;18: R880-R889.
32. Earley S, Brayden JE. Transient receptor potential channels and vascular function. Clin Sci (Lond). 2010;119:19-36.
33. Bautista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell. 2006;124: 1269-1282.
34. McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007;104:13525-13530. (Pubitemid 47293978)
35. Peier AM, Reeve AJ, Andersson DA, et al. A heat-sensitive TRP channel expressed in keratinocytes. Science. 2002;296:2046-2049. (Pubitemid 34627531)
36. Xu H, Ramsey IS, Kotecha SA, et al. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature. 2002;418:181-186. (Pubitemid 34773772)
37. Smith GD, Gunthorpe MJ, Kelsell RE, et al. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature. 2002;418:186-190. (Pubitemid 34773773)
38. Xu H, Delling M, Jun JC, et al. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci. 2006;9: 628-635. (Pubitemid 44012260)
39. Fisslthaler B, Popp R, Kiss L, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497. (Pubitemid 29470209)
40. Earley S, Pastuszyn A, Walker BR. Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia. Am J Physiol Heart Circ Physiol. 2003;285:H127-H136. (Pubitemid 36736423)
41. Campbell WB, Gebremedhin D, Pratt PF, et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423. (Pubitemid 26072547)
42. Watanabe H, Vriens J, Prenen J, et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003; 424:434-438. (Pubitemid 36917492)
43. Strotmann R, Harteneck C, Nunnenmacher K, et al. OTRPC4, a non-selective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol. 2000;2:695-702.
44. Watanabe H, Davis JB, Smart D, et al. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem. 2002;277: 13569-13577. (Pubitemid 34967954)
45. Willette RN, Bao W, Nerurkar S, et al. Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: part 2. J Pharmacol Exp Ther. 2008;326:443-452.
46. Thorneloe KS, Sulpizio AC, Lin Z, et al. N-((1S)-1-{[4-((2S)-2-{[(2,4- dichlorophe-nyl)sulfonyl]amino}-3-hydroxypropa noyl)-1-piperazinyl]carbonyl}-3- methyl-butyl)-1-benzothiophene-2-carboxamid e (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: part I. J Pharmacol Exp Ther 2008; 326: 432-442.
47. Guler AD, Lee H, Iida T, et al. Heat-evoked activation of the ion channel, TRPV4. J Neurosci. 2002;22:6408-6414. (Pubitemid 35386397)
48. Watanabe H, Vriens J, Suh SH, et al. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem. 2002;277:47044-47051. (Pubitemid 36159212)
49. Alvarez DF, King JA, Weber D, et al. Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury. Circ Res. 2006;99:988-995. (Pubitemid 44657802)
50. Marrelli SP, O'Neil RG, Brown RC, et al. PLA2 and TRPV4 channels regulate endothelial calcium in cerebral arteries. Am J Physiol Heart Circ Physiol. 2007;292:H1390-H1397. (Pubitemid 46377126)
51. Earley S, Pauyo T, Drapp R, et al. TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure. Am J Physiol Heart Circ Physiol. 2009;297:H1096-H1102.
52. Mendoza SA, Fang J, Gutterman DD, et al. TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol. 2010;298:H466-H476.
53. Kohler R, Heyken WT, Heinau P, et al. Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler Thromb Vasc Biol. 2006;26:1495-1502. (Pubitemid 44288974)
54. Zhang DX, Mendoza SA, Bubolz AH, et al. Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo. Hypertension. 2009;53:532-538.
55. Hartmannsgruber V, Heyken WT, Kacik M, et al. Arterial response to shear stress critically depends on endothelial TRPV4 expression. PLoS One. 2007;2:e827.
56. Loot AE, Popp R, Fisslthaler B, et al. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation. Cardiovasc Res. 2008;80:445-452.
57. Kotlikoff MI. EDHF redux: EETs, TRPV4, and Ca2+ sparks. Circ Res. 2005;97:1209-1210. (Pubitemid 43755174)
58. Iliff JJ, Wang R, Zeldin DC, et al. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels. Am J Physiol Heart Circ Physiol. 2009;296:H1352-H1363.
59. Harder DR, Alkayed NJ, Lange AR, et al. Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke. 1998;29:229-234. (Pubitemid 28046968)
60. Spector AA, Fang X, Snyder GD, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004;43:55-90. (Pubitemid 37433867)